Russia's Vaccine Development: A Geopolitical Race

In recent years, Russia has tried to reassert its global influence in many ways, from military action in Ukraine to meddling in U.S. elections.

So when Russia developed a coronavirus vaccine, it prioritized exporting it to dozens of other countries — at the expense of its own people.

Today, we look at how Russia has put vaccine diplomacy to work. 

Guest: Andrew E. Kramer, a reporter based in the Moscow bureau of The New York Times. 

Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. 

Background reading: 

• The Kremlin has scored propaganda points and bolstered several longstanding foreign policy goals by offering its Sputnik V vaccine around the world. But production capacity is limited.
• A microstate surrounded by Italy, San Marino feared being left behind in Europe’s inoculation campaign. Now it has jumped ahead, with the Sputnik vaccine.

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. 

Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.